Fluocinonide NDC 68071-2202

NDC codes

FDA NDC Directory

Product NDC (as listed)68071-2202Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68071-2202Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68071-2202-5	68071220205	1 TUBE in 1 CARTON (68071-2202-5) / 15 g in 1 TUBEMarketed from Jun 25, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: NuCare Pharmaceuticals,Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 073481
Marketing start: May 1, 1992
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 68071-2202_1d75dc5e-3f67-d0c3-e063-6294a90aac2bSPL ID 1d75dc5e-3f67-d0c3-e063-6294a90aac2bSPL set ID a8eefd01-340e-5eef-e053-2a95a90a802cRxCUI 103457UNII 2W4A77YPANUPC 0368071220254
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468071220205 followed by a unit qualifier and the quantity

Package 68071-2202-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE The topical corticosteriods are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 073481

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 073481
Product	Strength	Form · route	Labeler	Product NDC
Fluocinonide	Fluocinonide .5 mg/g	OintmentTopical	Teva Pharmaceuticals USA, Inc.	0093-0264